Tres procent (60%) af patienterne i placebogruppen nåede denne blodtryksværdi, mns tallet var henholdvis 76% og 78% for irbesartan og amlodipin.
Sixty per cent (60%) of patients in the placebo group reached this target blood pressure whereas this figure was 76% and 78% in the irbesartan and amlodipine groups respectively.